Peter Carmeliet's laboratory is focusing on unraveling the molecular and cellular basis of the formation of blood vessels (angiogenesis) in health and disease, and in particular the role of vascular heterogeneity and vascular metabolism herein. Abnormal blood vessel growth, excessive or insufficient, contributes to multiple disorders, including cancer, age-related blindness, stroke, diabetes, etc. Our ambition is to identify novel therapeutic pro- or anti-angiogenic treatments.
